{"id":"W2079406970","doi":"10.1016/j.ygyno.2005.12.004","title":"Synergistic effects of combined therapy using paclitaxel and [90Y-DOTA]776.1 on growth of OVCAR-3 ovarian carcinoma xenografts","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Radioimmunotherapy; Paclitaxel; Medicine; Ovarian cancer; Monoclonal antibody; In vivo; Chemotherapy; Cancer research; Combination therapy; Antibody; Oncology; Pharmacology; Cancer; Internal medicine; Immunology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018916,0.0001829677,0.0006242316,0.00007749014,0.00007239781,0.000003516325,0.0001022372,0.0002527425,0.00007441704],"category_scores_gemma":[0.0003071128,0.0001488672,0.00009283832,0.0002344678,0.0004348288,0.00002102022,0.00003548891,0.000216808,0.000002873975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001169441,"about_ca_system_score_gemma":0.0001274094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009033926,"about_ca_topic_score_gemma":0.000002877664,"domain_scores_codex":[0.9987697,0.0001150283,0.0004090806,0.0002975345,0.0001312047,0.0002774728],"domain_scores_gemma":[0.9978587,0.001447997,0.000216694,0.0002475562,0.0001099478,0.0001190803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007537877,0.002542235,0.0548446,0.0006024697,0.0001190161,0.0001780782,0.00006883449,0.00002463303,0.9252955,0.01253889,0.0005236862,0.002508319],"study_design_scores_gemma":[0.009468046,0.006457482,0.4343534,0.0000728204,0.0003658202,0.00006841048,0.00005157425,0.0007408619,0.5415881,0.005150133,0.001422137,0.0002612756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918683,0.000434852,0.0001180068,0.0007600281,0.000129293,0.0006025301,0.00001173304,0.00003446025,0.006040758],"genre_scores_gemma":[0.9982057,0.00006497684,0.00102446,0.0004020308,0.0001224884,0.00005616975,0.00002132017,0.00001447147,0.00008844829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3837074,"threshold_uncertainty_score":0.6070627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02628249652665323,"score_gpt":0.3162870287131962,"score_spread":0.290004532186543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}